Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2020
Sep. 30, 2019
Current Assets    
Cash and cash equivalents $ 46,436 $ 52,982
Restricted cash   101
Accounts receivable (less allowance for doubtful accounts of $138 and $172 at June 30, 2020, and September 30, 2019, respectively) 10,297 12,873
Inventories 19,385 17,532
Notes and other receivables 1,250  
Income taxes receivable 150  
Held-for-sale assets   22,755
Other current assets 3,066 2,027
Total current assets 80,584 108,270
Property, Plant and Equipment - Net 10,438 10,217
Right-of-Use Assets - Net 5,162  
Intangible Assets - Net 674 870
Goodwill - Net 6,633 6,633
Other Assets 565 487
Total Assets 104,056 126,477
Current Liabilities    
Accounts payable 3,933 4,371
Accrued compensation and related taxes 1,983 2,717
Accrued warranty expense 401 556
Other accrued liabilities 1,478 1,274
Current maturities of long-term debt 376 371
Contract liabilities 1,645 1,378
Income taxes payable   1,434
Held-for-sale liabilities   18,547
Total current liabilities 9,816 30,648
Long-Term Debt 4,894 5,178
Long-Term Lease Liability 5,088  
Income Taxes Payable 2,007 3,199
Total Liabilities 21,805 39,025
Commitments and Contingencies
Shareholders’ Equity    
Preferred stock; 100,000,000 shares authorized; none issued
Common stock; $0.01 par value; 100,000,000 shares authorized; shares issued and outstanding: 14,048,172 and 14,268,797 at June 30, 2020 and September 30, 2019, respectively 140 143
Additional paid-in capital 124,289 125,098
Accumulated other comprehensive loss (1,792) (11,233)
Retained deficit (40,386) (26,556)
Total shareholders’ equity 82,251 87,452
Total Liabilities and Shareholders’ Equity $ 104,056 $ 126,477